Evidence map›Paper›PMID 37850857›Full record

ReviewJournal of cell science2023

Atypical MAP kinases - new insights and directions from amoeba.

Jeffrey A Hadwiger, Ramee G Aranda, Saher Fatima

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of cell science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Atypical MAPKs in cancer.The FEBS journal · 2025
    Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jeffrey A HadwigerDepartment of Microbiology and Molecular Genetics, Oklahoma State University, Stillwater, OK 74078-3020, USA.ORCID 0000-0001-7968-094X
Ramee G ArandaDepartment of Microbiology and Molecular Genetics, Oklahoma State University, Stillwater, OK 74078-3020, USA.
Saher FatimaDepartment of Microbiology and Molecular Genetics, Oklahoma State University, Stillwater, OK 74078-3020, USA.
Oklahoma State University · US

Funding

G-RISE at Oklahoma State UniversityT32GM140953 · NIGMS · OKLAHOMA STATE UNIVERSITY STILLWATER · PI LOVERN, MATTHEW, LOVERN, PAMELA C · 2021 to 2024
$1.5M
Atypical MAP Kinase Signal TransductionR15GM131269 · NIGMS · OKLAHOMA STATE UNIVERSITY STILLWATER · PI HADWIGER, JEFFREY A · 2019 to 2022
$914k
NIGMS NIH HHS R15 GM131269NIGMS NIH HHS T32 GM140953
6 · The paper itself

Abstract

Mitogen-activated protein kinases (MAPKs) have been the focus of many studies over the past several decades, but the understanding of one subgroup of MAPKs, orthologs of MAPK15, known as atypical MAPKs, has lagged behind others. In most organisms, specific activating signals or downstream responses of atypical MAPK signaling pathways have not yet been identified even though these MAPKs are associated with many eukaryotic processes, including cancer and embryonic development. In this Review, we discuss recent studies that are shedding new light on both the regulation and function of atypical MAPKs in different organisms. In particular, the analysis of the atypical MAPK in the amoeba Dictyostelium discoideum has revealed important roles in chemotactic responses and gene regulation. The rapid and transient phosphorylation of the atypical MAPK in these responses suggest a highly regulated activation mechanism in vivo despite the ability of atypical MAPKs to autophosphorylate in vitro. Atypical MAPK function can also impact the activation of other MAPKs in amoeba. These advances are providing new perspectives on possible MAPK roles in animals that have not been previously considered, and this might lead to the identification of potential targets for regulating cell movement in the treatment of diseases.

Indexed as

AmoebaDictyosteliumAnimalsGene Expression RegulationMAP Kinase Signaling SystemMitogen-Activated Protein Kinase KinasesPhosphorylationMitogen-Activated Protein Kinase KinasesCancerChemotaxisDictyosteliumMAP kinaseSignal transductionTranscription factor

Identifiers

PMID37850857
PMCPMC10617611
OpenAlexW4387728892

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.